Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections

Telbivudine in the treatment of chronic hepatitis B

(2009) Kathryn Nash   ADVANCES IN THERAPY

Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA

(2009) Jung Im Seok et al.   HEPATOLOGY

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

(2009) Daniel J. Tenney et al.   HEPATOLOGY

Chronic hepatitis B: Update 2009

(2009) Anna S. F. Lok et al.   HEPATOLOGY

Clevudine myopathy in patients with chronic hepatitis B

(2009) Byung Kook Kim et al.   JOURNAL OF HEPATOLOGY

Baseline characteristics and early on-treatment response predict the outcomes of 2years of telbivudine treatment of chronic hepatitis B

(2009) Stefan Zeuzem et al.   JOURNAL OF HEPATOLOGY

HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues

(2009) Pietro Lampertico et al.   LIVER INTERNATIONAL

Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure

(2009) Fabien Zoulim et al.   LIVER INTERNATIONAL

New Drugs for Chronic Hepatitis B: A Review

(2008) Emilio Palumbo   AMERICAN JOURNAL OF THERAPEUTICS

Entecavir Exhibits Inhibitory Activity against Human Immunodeficiency Virus under Conditions of Reduced Viral Challenge

(2008) P.-F. Lin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Lack of an Effect of Human Immunodeficiency Virus Coinfection on the Pharmacokinetics of Entecavir in Hepatitis B Virus-Infected Patients

(2008) M. Zhu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir

(2008) Maria Seifer et al.   ANTIVIRAL RESEARCH

Inhibition of the replication of hepatitis B virus in vitro by a novel 2,6-diaminopurine analog, β-LPA

(2008) Xing-Xing He et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Therapy of chronic hepatitis B: trends and developments

(2008) W DELANEYIV et al.   CURRENT OPINION IN PHARMACOLOGY

Entecavir monotherapy for lamivudine-refractory chronic hepatitis B

(2008) Ioannis Goulis et al.   Expert Review of Anti-Infective Therapy

2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B

(2008) Yun–Fan Liaw et al.   GASTROENTEROLOGY

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

(2008) Carl J. Baldick et al.   HEPATOLOGY

Entecavir therapy for lamivudine‐refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks

(2008) Morris Sherman et al.   HEPATOLOGY

The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains

(2008) Samad Amini-Bavil-Olyaee et al.   HEPATOLOGY

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

(2008) Maurizia Rossana Brunetto et al.   HEPATOLOGY

Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B

(2008) Teerha Piratvisuth   Hepatology International

Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase

(2008) Egor P. Tchesnokov et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

696 ADD ON ADEFOVIR PREVENTS THE EMERGENCE OF ADV RESISTANCE IN LAMIVUDINE-RESISTANT PATIENTS: A 4-YEAR STUDY

(2008) P. Lampertico et al.   JOURNAL OF HEPATOLOGY

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response

(2008) Carl J. Baldick et al.   JOURNAL OF HEPATOLOGY

Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations

(2008) Jessica Tan et al.   JOURNAL OF HEPATOLOGY

Hepatitis B: Reflections on the current approach to antiviral therapy

(2008) Fabien Zoulim et al.   JOURNAL OF HEPATOLOGY

Entecavir shows limited efficacy in HBeAg-positive hepatitis B patients with a partial virologic response to adefovir therapy

(2008) Jurriën G.P. Reijnders et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

(2008)   JOURNAL OF HEPATOLOGY

Synthesis and Anti-Hepatitis B Virus and Anti-Hepatitis C Virus Activities of 7-Deazaneplanocin A Analogues in Vitro

(2008) Hyo-Joong Kim et al.   JOURNAL OF MEDICINAL CHEMISTRY

Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B

(2008) A. Gallego et al.   JOURNAL OF VIRAL HEPATITIS

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

(2008) Patrick Marcellin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication

(2007) Brent E. Korba et al.   ANTIVIRAL RESEARCH

Tenofovir-Based Rescue Therapy for Advanced Liver Disease in 6 Patients Coinfected with HIV and Hepatitis B Virus and Receiving Lamivudine

(2007) S. Gutierrez et al.   CLINICAL INFECTIOUS DISEASES

Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach

(2007) Jean–Michel Pawlotsky et al.   GASTROENTEROLOGY

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection

(2007) George V Papatheodoridis et al.   LANCET INFECTIOUS DISEASES